CAS 172822-29-6
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 prodotti.
Aprepitant Related Compound B (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H21F7N4O3Colore e forma:White Off-White Crystalline PowderPeso molecolare:534.150193-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one ((S,R,S)-Aprepitant)
CAS:Prodotto controllatoFormula:C23H21F7N4O3Colore e forma:NeatPeso molecolare:534.43Ref: ST-EA-CP-A109008
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaent-aprepitant
CAS:<p>Aprepitant is a drug that belongs to the class of antiemetics. It is an antagonist of the neurokinin-1 receptor (NK-1R) and blocks the apical portion of the NK-1R, preventing binding of substance P. Aprepitant also has been shown to have a matrix effect on human pharmacokinetics in vitro and to inhibit p450 activity in human serum. This drug has been found to induce apoptosis by inhibiting the expression of pro-apoptotic proteins and activating pro-survival proteins. Aprepitant has also been shown to be effective in treating solid tumours, particularly colorectal cancer, with synergism with chemotherapy drugs such as trifluoroacetic acid.</p>Formula:C23H21F7N4O3Purezza:Min. 95%Colore e forma:White To Off-White SolidPeso molecolare:534.43 g/molent-Aprepitant-13C15N2
CAS:Prodotto controllatoFormula:CC22H21F715N2N2O3Colore e forma:NeatPeso molecolare:537.406
![3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM3251.02.jpg&w=3840&q=75)
